HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Purpurogallin as a cytoprotector of cultured rabbit corneal endothelium.

Abstract
We examined the protective properties of purpurogallin, a naturally occurring phenol, in delaying necrosis of cultured corneal endothelial cells caused by oxygen free radicals. Endothelial cell cultures were prepared from New Zealand white rabbits using microcarrier cell culture techniques. Corneal endothelial cells were treated with hypoxanthine (2 mM) and xanthine oxidase (67 IU/L) to generate free radicals. The criteria for cell necrosis were cytoplasmic shrinkage, dissolution of plasma membranes and presence of "haloes" around the cells on phase contrast microscopy, confirmed by transmission electron microscopy. More than 95% of second-generation cells exhibited morphologic evidence of necrosis within 4.62 +/- 0.82 minutes after exposure to oxyradicals. The addition of purpurogallin (0.25 or 1.0 mM) significantly increased time to cell necrosis to 8.18 +/- 0.83 and 11.59 +/- 1.71 minutes respectively (p < 0.05). Further studies are under way to determine whether purpurogallin may be useful in preventing endothelial cell damage in corneas preserved for corneal transplantation.
AuthorsD S Rootman, R Bindish, L H Zeng, S M Hasany, T W Wu
JournalCanadian journal of ophthalmology. Journal canadien d'ophtalmologie (Can J Ophthalmol) Vol. 29 Issue 5 Pg. 220-3 (Oct 1994) ISSN: 0008-4182 [Print] England
PMID7859173 (Publication Type: Journal Article)
Chemical References
  • Benzocycloheptenes
  • Cryoprotective Agents
  • Free Radical Scavengers
  • Hypoxanthines
  • Hypoxanthine
  • Xanthine Oxidase
  • purpurogallin
Topics
  • Animals
  • Benzocycloheptenes (pharmacology)
  • Cell Death (drug effects)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Cryoprotective Agents (pharmacology)
  • Endothelium, Corneal (drug effects, ultrastructure)
  • Free Radical Scavengers
  • Hypoxanthine
  • Hypoxanthines (pharmacology)
  • Rabbits
  • Xanthine Oxidase (antagonists & inhibitors, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: